欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/1142/002
药品名称Carbidopa/Levodopa Orion 25 mg / 100 mg
活性成分
    • Carbidopa 27.0 mg
    • Levodopa 100.0 mg
剂型Tablet
上市许可持有人Orion Corporation Orionintie 1 02200 Espoo Finland
参考成员国 - 产品名称Finland (FI)
Carbidopa/Levodopa Orion
互认成员国 - 产品名称
    • Slovenia (SI)
    • Poland (PL)
    • Hungary (HU)
      Parlekarv 100 mg / 25 mg tabletta
    • Czechia (CZ)
      Carlevo
    • Slovakia (SK)
    • Belgium (BE)
    • Denmark (DK)
    • Ireland (IE)
    • Netherlands (NL)
    • Spain (ES)
    • Portugal (PT)
    • Sweden (SE)
    • Italy (IT)
    • Norway (NO)
许可日期2022/12/02
最近更新日期2024/12/13
药物ATC编码
    • N04BA02 levodopa and decarboxylase inhibitor
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase